Skip to content
Screener

Collegium Pharmaceutical, Inc. COLL Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$9M-18.2%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$1.72M+133%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$9.82M+4.4%
Bioventus logo
BioventusBVS
$3.18M-10.3%
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
$57.31K+13.0%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$503.02K+30.3%

Segments

By geography

See full
Stoughton, Massachusetts$5.01M

Other financials

Income statement

See full
Revenue$199.9M+6.3%
Gross profit$110.3M+1.8%
Operating income$3.7M-89.5%
Net income-$15.1M-226%
EPS (diluted)-$0.46-235%

Balance sheet

See full
Cash & equivalents$150.4M+8.8%
Total debt$5.0M-19.8%
Total equity$311.9M+34.3%
Total assets$2.1B+34.1%

Cash flow

See full
Operating cash flow$71.3M-1.5%
CapEx$496.0K+663%
Free cash flow$70.8M-2.1%

Valuation

See full
Market cap$955.82M-16.0%
Enterprise value$810.41M-19.5%
P/E20×-11.4×
P/S1.2×-0.4×

Profitability

See full
Gross margin60%+3.3pp
Operating margin19.5%+1.1pp
Net margin5.9%+0.8pp
FCF margin40.6%+10.8pp

Returns & leverage

See full
Return on equity17.6%+1.4pp
Debt / equity0.0×
Current ratio-0.2×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:34 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053851

FAQ

What is Collegium Pharmaceutical, Inc.'s operating lease liabilities (current)?
Collegium Pharmaceutical, Inc. (COLL) reported operating lease liabilities (current) of $1.56M in Q2 2026.
How has Collegium Pharmaceutical, Inc.'s operating lease liabilities (current) changed year-over-year?
Collegium Pharmaceutical, Inc.'s operating lease liabilities (current) increased by 16.7% year-over-year, from $1.34M to $1.56M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s operating lease liabilities (current)?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s operating lease liabilities (current) has grown at a 14.0% compound annual growth rate (CAGR), from $730K to $1.41M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Collegium Pharmaceutical, Inc.'s operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude